Patenting and Licensing of University Research: Promoting Innovation or Undermining Academic Values?
Creator
Sterckx, Sigrid
Bibliographic Citation
Science and engineering ethics 2011 Mar; 17(1): 45-64
Abstract
Since the 1980s in the US and the 1990s in Europe, patenting and licensing activities by universities have massively increased. This is strongly encouraged by governments throughout the Western world. Many regard academic patenting as essential to achieve 'knowledge transfer' from academia to industry. This trend has far-reaching consequences for access to the fruits of academic research and so the question arises whether the current policies are indeed promoting innovation or whether they are instead a symptom of a pro-intellectual property (IP) culture which is blind to adverse effects. Addressing this question requires both empirical analysis (how real is the link between academic patenting and licensing and 'development' of academic research by industry?) and normative assessment (which justifications are given for the current policies and to what extent do they threaten important academic values?). After illustrating the major rise of academic patenting and licensing in the US and Europe and commenting on the increasing trend of 'upstream' patenting and the focus on exclusive as opposed to non-exclusive licences, this paper will discuss five negative effects of these trends. Subsequently, the question as to why policymakers seem to ignore these adverse effects will be addressed. Finally, a number of proposals for improving university policies will be made.
Date
2011-03Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Current controversies in prenatal diagnosis 4: does industry-sponsorship accelerate or hinder the pace of research?
Sterckx, Sigrid; Worthington, Gajus; Van Steirteghem, André (2011-03) -
Gene patenting and licensing: the role of academic researchers and advocacy groups
Ledbetter, David H. (2008-05) -
Press Conference on Gene Patenting Legislation, March 14, 2002. Packet of materials distributed at the press conference including: Statement by Rep. Rivers; Letters and statements endorsing the gene patenting legislation; Section-by-section analysis of H.R. 3966, The Genomic Research and Diagnostic Accessibility Act of 2002, and H.R. 3967, The Genomic Science and Technology Innovation Act of 2002
Rivers, Lynn N.; Raslavicus, Paul; Dorman, Diane E.; Leonard, Debra G.B.; Shestack, Jonathan; Andrews, Lori; Annas, George J.; Greenberg, Daniel; Norsigian, Judy; Young, Quentin D.; College of American Pathologists; National Organization for Rare Disorders; Association of Molecular Pathologists; Academy of Clinical Laboratory Physicians and Scientists; American College of Medical Genetics; Association of American Medical Colleges; CyGene, Inc. (2002-03-14)